UnitedHealth Group Incorporated $UNH Stock Holdings Decreased by Cullen Capital Management LLC

Cullen Capital Management LLC lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 5.0% during the third quarter, Holdings Channel.com reports. The firm owned 451,900 shares of the healthcare conglomerate’s stock after selling 23,619 shares during the quarter. UnitedHealth Group makes up about 1.7% of Cullen Capital Management LLC’s investment portfolio, making the stock its 28th biggest position. Cullen Capital Management LLC’s holdings in UnitedHealth Group were worth $165,883,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the company. Corient Private Wealth LP purchased a new stake in shares of UnitedHealth Group during the second quarter valued at about $245,516,000. Legal & General Group Plc purchased a new position in shares of UnitedHealth Group in the 2nd quarter worth approximately $2,444,928,000. Jupiter Topco LLC purchased a new position in shares of UnitedHealth Group in the 2nd quarter worth approximately $2,019,844,000. BlackRock Inc. raised its stake in shares of UnitedHealth Group by 4.6% during the 2nd quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock worth $31,946,594,000 after acquiring an additional 3,395,530 shares in the last quarter. Finally, Canada Pension Plan Investment Board purchased a new stake in UnitedHealth Group during the second quarter valued at approximately $971,757,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Up 1.0%

Shares of UNH stock opened at $411.65 on Tuesday. UnitedHealth Group Incorporated has a fifty-two week low of $255.96 and a fifty-two week high of $461.62. The firm has a market capitalization of $368.84 billion, a PE ratio of 23.51, a P/E/G ratio of 1.47 and a beta of 0.51. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.74 and a current ratio of 0.74. The stock’s 50-day simple moving average is $391.66 and its 200-day simple moving average is $366.24.

UnitedHealth Group (NYSE:UNH – Get Free Report) last released its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, topping analysts’ consensus estimates of $4.14 by $0.55. The firm had revenue of $112.72 billion during the quarter, compared to the consensus estimate of $111.31 billion. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The company’s revenue was down .4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.59 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. Equities analysts expect that UnitedHealth Group Incorporated will post 20.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Monday, December 7th will be given a dividend of $2.32 per share. The ex-dividend date of this dividend is Monday, December 7th. This represents a $9.28 dividend on an annualized basis and a yield of 2.3%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 53.00%.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of UnitedHealth Group stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the sale, the chief executive officer directly owned 15,328 shares in the company, valued at approximately $5,977,920. The trade was a 7.09% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 0.19% of the company’s stock.

Wall Street Analysts Forecast Growth

UNH has been the subject of several recent analyst reports. HC Wainwright set a $500.00 target price on shares of UnitedHealth Group in a research note on Friday, October 16th. Zacks Research downgraded UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 14th. Raymond James Financial reiterated an “outperform” rating and set a $450.00 price objective on shares of UnitedHealth Group in a report on Thursday, October 15th. Stephens set a $500.00 price objective on UnitedHealth Group in a research report on Friday, October 16th. Finally, Weiss Ratings upgraded UnitedHealth Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Thursday, October 8th. Twenty equities research analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average target price of $463.93.

Get Our Latest Stock Analysis on UNH

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.